These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 33740993
1. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report. Kishi T, Tani Y, Okiyama N, Mizuochi K, Ichimura Y, Harigai M, Nagata S, Miyamae T. Pediatr Rheumatol Online J; 2021 Mar 19; 19(1):34. PubMed ID: 33740993 [Abstract] [Full Text] [Related]
2. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report. Nainia K, Aouzal MA, Ouafik I, Charhbili M, Bouchhab A, Daoudi A, Tizki S, Chakiri R. Pediatr Rheumatol Online J; 2024 May 21; 22(1):57. PubMed ID: 38773611 [Abstract] [Full Text] [Related]
3. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review. Nishi K, Ogura M, Tamai N, Gima M, Ide K, Koinuma G, Kamei K, Ito S. Pediatr Rheumatol Online J; 2022 Aug 04; 20(1):60. PubMed ID: 35927666 [Abstract] [Full Text] [Related]
4. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review. Yeung TW, Cheong KN, Lau YL, Tse KN. Pediatr Rheumatol Online J; 2021 Jun 30; 19(1):103. PubMed ID: 34193210 [Abstract] [Full Text] [Related]
8. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review]. Hou J, Zhou ZX, Li JG, Xu YJ, Ding YC. Zhonghua Er Ke Za Zhi; 2019 Dec 02; 57(12):928-933. PubMed ID: 31795559 [Abstract] [Full Text] [Related]
10. Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report. Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A. Medicine (Baltimore); 2018 Apr 02; 97(15):e0436. PubMed ID: 29642214 [Abstract] [Full Text] [Related]
12. New-onset dermatomyositis following COVID-19: A case report. Shimizu H, Matsumoto H, Sasajima T, Suzuki T, Okubo Y, Fujita Y, Temmoku J, Yoshida S, Asano T, Ohira H, Ejiri Y, Migita K. Front Immunol; 2022 Apr 02; 13():1002329. PubMed ID: 36353621 [Abstract] [Full Text] [Related]
13. 14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report. Kinkor M, Hameed S, Kats A, Slowik V, Fox E, Ibarra M. Pediatr Rheumatol Online J; 2024 Sep 17; 22(1):86. PubMed ID: 39289679 [Abstract] [Full Text] [Related]
17. Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient. Li ZY, Gill E, Mo F, Reyes C. BMC Pulm Med; 2020 Aug 15; 20(1):220. PubMed ID: 32799827 [Abstract] [Full Text] [Related]